河北地区侵袭性酵母样真菌的菌株分布及药敏分析

中国真菌学杂志　 2019, Vol. 14 　Issue (4): 222-227.

河北地区侵袭性酵母样真菌的菌株分布及药敏分析

栗方¹, 李志荣², 赵颖³, 赵建宏², 张延海⁴, 董爱英⁵, 刘金禄⁶, 郭彦言⁷, 孙艳⁸, 赵文申⁹, 谢守军¹⁰, 魏宏莲¹¹, 张金艳¹², 任宏涛¹³, 王建升¹⁴, 吴相锟⁴, 光晓¹⁵, 刘冬青¹⁶, 杜红丽¹⁷, 郭映辉¹⁸, 徐英春³, 肖盟³, 杨文航³, 徐晓琳⁴

1. 河北燕达医院感染与疾病控制部, 廊坊 065201;首都医科大学附属北京朝阳医院感染与微生物科, 北京 100020;
2. 河北医科大学第二医院河北省临床检验中心, 石家庄 050000;
3. 中国医学科学院北京协和医院检验科侵袭性真菌病机制研究与精准诊断北京市重点实验室, 北京 100730;
4. 河北燕达医院, 廊坊 065201;
5. 华北理工大学附属医院, 唐山 063000;
6. 河北北方学院附属第一医院, 张家口 075000;
7. 河北省唐山市工人医院, 唐山 063000;
8. 沧州市中心医院, 沧州 061001;
9. 邯郸市中心医院, 邯郸 056001;
1
0. 承德医学院附属医院, 承德 067000;
1
1. 河北医科大学第二医院, 石家庄 050000;
1
2. 河北医科大学第四医院, 石家庄 050019;
1
3. 邢台市人民医院, 邢台 054001;
1
4. 河北省人民医院, 石家庄 050057;
1
5. 河北省武安市第一人民医院, 武安 056300;
1
6. 邯郸市第一医院, 邯郸 056002;
1
7. 衡水市人民医院, 衡水 053000;
1
8. 河北省儿童医院, 石家庄 050030

收稿日期:2019-05-12 出版日期:2019-08-28 发布日期:2019-08-28
通讯作者: 赵颖,E-mail:zhaoying28062806@163.com;赵建宏,E-mail:1543838793@qq.com E-mail:zhaoying28062806@163.com;1543838793@qq.com
作者简介:栗方,女(汉族),本科,副主任技师.E-mail:lifang280@sohu.com
基金资助:
河北省科技计划-重点研发计划项目资助（17277775D）；中央高校基本科研业务费专项资金资助项目（3332018041）；辉瑞中国抗真菌科研基金项目资助（WS931592）

Isolates distribution and drug sensitivity test of invasive yeast-like fungi infection in Hebei

LI Fang¹, LI zhi-rong², ZHAO Ying³, ZHAO Jian-hong², ZHANG Yan-hai⁴, DONG Ai-ying⁵, LIU Jin-lu⁶, GUO Yan-yan⁷, SUN Yan⁸, ZHAO Wen-shen⁹, XIE Shou-jun¹⁰, WEI Hong-lian¹¹, ZHANG Jin-yan¹², REN Hong-tao¹³, WANG Jian-sheng¹⁴, WU Xiang-kun⁴, GUANG Xiao¹⁵, LI Dong-qing¹⁶, DU Hong-li¹⁷, GUO Ying-hui¹⁸, XU Ying-chun³, XIAO Meng³, YANG Wen-Hang³, XU Xiao-lin⁴

1. Herbei Yanda hopstial, Langfang 065201;Chao yang Hospital Affilliated to the Capital University of Medical Science, Beijing 100020, China;
2. The Second Hospital of Hebei Medical University, Clinical Laboratory Center of Hebei Province, Shijiazhuang 050000, China;
3. Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences;Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing 100730, China;
4. Herbei Yanda hopstial, Langfang 065201;
5. North China University of Science and Technology Affiliated Hospital, Tangshan 063000;
6. The First Affiliated Hospital of Hebei North University School of Clinical Medicine, Zhangjiakou 075000;
7. Department of Endocrinology, Tangshan Gongren Hospital, Tangshan 063000;
8. Cangzhou Central Hospital, Cangzhou 061001;
9. The Central Hospital of Handan, Handan 056001;
1
0. Affiliated Hospital of Chengde Medical College, Chengde 067000;
1
1. The Second Hospital of Hebei Medical University, Shijiazhuang 050000;
1
2. Fourth Hospital Affiliated to Hebei Medical University, Shijiazhuang 050019;
1
3. People's Hospital of Xingtai City, Xingtai 054001;
1
4. Hebei Provincial People's Hospital, Shijiazhuang 050057;
1
5. The First People's Hospital of Wu'an City, Wuan 056300;
1
6. Handan First People's Hospital, Handan 056002;
1
7. People's Hospital of Hengshui City, Hengshui 053000;
1
8. Hebei Children's Hospital, Shijiazhuang 050030

Received:2019-05-12 Online:2019-08-28 Published:2019-08-28

摘要/Abstract

摘要：

目的调查河北地区16家三级教学医院侵袭性酵母样真菌的菌株构成、分布及其体外药敏特点，为临床抗真菌药物的合理应用提供依据。方法收集河北地区2016~2017年侵袭性酵母样真菌感染患者的菌株，对菌种构成进行分析，采用Sensititre YeastOne显色药敏板对9种抗真菌药进行药敏试验。结果共检出侵袭性酵母样真菌260株，其中白念珠菌是最主要的致病菌，占42.31%；非白念珠菌占57.69%，主要包括热带念珠菌19.23%、近平滑念珠菌18.08%和光滑念珠菌9.23%。白念珠菌对氟康唑、伏立康唑、伊曲康唑的耐药率分别为2.8%、1.9%和0.9%；热带念珠菌对氟康唑和伏立康唑的耐药率均为12.8%；近平滑念珠菌复合体对氟康唑和伏立康唑的耐药率分别为14.9%和10.6%；白念珠菌、热带念珠菌和近平滑念珠菌复合体对棘白菌素类抗菌物的耐药率几乎0%。结论侵袭性酵母样真菌感染中最常见的是白念珠菌感染，但是非白念珠菌感染已经超过50%。白念珠菌对抗真菌药物仍然有较高的敏感性，但对唑类药物的敏感率在不同种的念珠菌中存在差异。棘白菌素类对白念珠菌、热带念珠菌和近平滑念珠菌有很高的抗菌活性。

关键词: 侵袭性酵母样真菌, 菌株分布, 药敏试验

Abstract:

Objective To investigate the composition, distribution and in vitro drug sensitivity of invasive yeast-like fungi infections isolates in 16 tertiary teaching hospitals in Hebei, and to provide a reference for the rational use of antifungal drugs. Methods The isolated strains of invasive yeast-like fungi infection patients in Hebei were collected, and the composition of the strains was analyzed, Sensititre YeastOne color sensitive plate was used to test the susceptibility of 9 antifungal agents. Results A total of 260 invasive yeast strains were detected, of which C. albicans was the most important pathogen (42.31%), and non-C.albicans (57.69%), including C.tropicalis (19.23%), C.parapsilosis complex(18.08%)and C.glabrata(9.23%).The resistance rates of C. albicans to fluconazole, voriconazole and itraconazole were 2.8%, 1.9% and 0.9%, respectively. The resistance rates of C.tropicalis to fluconazole and voriconazole were 12.8%. The resistance rates of C.parapsilosis complex to fluconazole and voriconazole were 14.9% and 10.6%, respectively. The resistance rate of C.albicans, C.tropicalis and C.parapsilosis complex to echinococcins was almost 0%. Conclusion C.albicans was the most common pathogen ofinvasive yeast-like fungi infection, but non-C.albicans infection had exceeded 50%. C. albicans was still highly susceptible to antifungal drugs, but the susceptibility rates of azoles were different among different Candida species. Echinomycins had high activity against C. albicans, C. tropicalis and C. parapsilosis.

Key words: invasive yeast fungi, distribution of strains, drug sensitivity test

中图分类号:

R519

栗方, 李志荣, 赵颖, 赵建宏, 张延海, 董爱英, 刘金禄, 郭彦言, 孙艳, 赵文申, 谢守军, 魏宏莲, 张金艳, 任宏涛, 王建升, 吴相锟, 光晓, 刘冬青, 杜红丽, 郭映辉, 徐英春, 肖盟, 杨文航, 徐晓琳. 河北地区侵袭性酵母样真菌的菌株分布及药敏分析[J]. 中国真菌学杂志, 2019, 14(4): 222-227.

LI Fang, LI zhi-rong, ZHAO Ying, ZHAO Jian-hong, ZHANG Yan-hai, DONG Ai-ying, LIU Jin-lu, GUO Yan-yan, SUN Yan, ZHAO Wen-shen, XIE Shou-jun, WEI Hong-lian, ZHANG Jin-yan, REN Hong-tao, WANG Jian-sheng, WU Xiang-kun, GUANG Xiao, LI Dong-qing, DU Hong-li, GUO Ying-hui, XU Ying-chun, XIAO Meng, YANG Wen-Hang, XU Xiao-lin. Isolates distribution and drug sensitivity test of invasive yeast-like fungi infection in Hebei[J]. Chinese Journal of Mycology, 2019, 14(4): 222-227.

参考文献

[1] 文细毛,任南,徐秀华,等.全国医院感染监控网医院感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2002,12(4):241-242.
[2] 黄丽菊,杨进军,符婷. ICU医院感染病原菌分布及控制研究[J].中华医院感染学杂志.2014,24(13):3164-3166.
[3] 杨继勇,赵慧,张军民. 酵母菌引起深部感染的病原学特征[J].中华医院感染学杂志,2003,26(9):579-580.
[4] Pappas PG, Kauffman CA, Andes D,et al. Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis,2009,48(5):503-535.
[5] Yenigün Koçak B, Kulolu F, Doan Çelik A, et al.Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital[J]. Mikrobiyol Bul, 2011,45(3):489-503.
[6] Arnold HM, Micek ST, Shorr AF, et al.Hospital resource utilization and costs of inappropriate treatment of candidemia[J]. Pharmacotherapy,2010,30(4):361-368.
[7] Chen LY, Liao SY, Kuo SC, et al. Changes in the incidence of candidaemia during 2000-2008 in a tertiary medical centre in northern Taiwan[J]. J Hosp Infect,2011,78(1):50-53.
[8] Panackal AA, Gribskov JL, Staab JF, et al:Clinical significance of azole antifungal drug cross-resistance in Candida glabrata[J]. J Clin Microbiol 2006,44(5):1740-1743.
[9] Spreghini E, Orlando F, Sanguinetti M, et al.Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata[J]. Antimicrob Agents Chemother, 2012,56(3):1215-1222.
[10] 杨莉莉,范严严,邓英,等.146株念珠菌的分布及药敏结果分析[J].中华医院感染学杂志,2004,14(6):703-704.
[11] Ying Li, He Wang, Yu-Pei Zhao,et al. Evaluation of the Bruker Biotyper matrix-assisted laser desorption/ionization time-of-flight mass spectrometry aystem for identification of Aspergillus species directly from growth on solid agar media[J]. Front Microbiol, 2017, 29(8):1209.
[12] Clinical and Laboratory Standards Institute. M60. Performance standards for antifungal susceptibility testing of yeasts, 1st ed[S]. Clinicaland Laboratory Standards Institute, Wayne, PA,2018.
[13] Pfaller MA, Diekema DJ.Progress in antifungal ausceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012[J]. J Clin Microbiol,2012,50(9):2846-2856.
[14] 中华人民共和国卫生部.侵袭性真菌病临床实验室操作指南.中华人民共和国卫生行业标准.WS/T497-2017[S].中华人民共和国卫生部,2017.
[15] 李华信,高春芳,李晓冰,等.医院深部真菌感染900例病原菌分布及耐药性监测[J].中华医院感染学,2010,20(13):1980-1983.
[16] Don AM,Pignatari AC,Edmond MB,et al.Epidemiology and microbiolgic characterization of nosocmial candidemia from a Brazilian National Surveillance Program[J].PLoS One,2016,11(1):e0146909.
[17] Pfaller MA, Diekema D, Gibbs D,et al.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007:a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion[J]. J Clin Microbiol,2010,48(4):1366-1377.
[18] 王贺,徐英春.中国多中心侵袭性酵母样真菌感染临床相关科学研究方法体系的探索和建立[D].北京协和医学院,2017.
[19] Chen TC, Chen YH, Chen YC, et al.Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents[J]. Kaohsiung J Med Sci,2012,28(6):306-315.